COVIDMED – An early pandemic randomized clinical trial of losartan treatment for hospitalized COVID-19 patientsShort communication Published on 2022-10-012022-10-30 Journal: Contemporary Clinical Trials Communications [Category] [DOI] 10.1016/j.conctc.2022.100968 [Article Type] Short communication
Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trialRandomized Controlled Trial Published on 2022-10-012022-10-04 Journal: Journal of Clinical Virology [Category] [DOI] 10.1016/j.jcv.2022.105248 PMC 바로가기 [Article Type] Randomized Controlled Trial
Pembrolizumab in combination with tocilizumab in high-risk hospitalized patients with COVID-19 (COPERNICO): A randomized proof-of-concept phase II studyClinical Trial Published on 2022-10-012022-10-05 Journal: International Journal of Infectious Diseases [Category] [DOI] 10.1016/j.ijid.2022.08.007 [Article Type] Clinical Trial
Effect of a diet based on Iranian traditional medicine on inflammatory markers and clinical outcomes in COVID-19 patients: A double-blind, randomized, controlled trialResearch article Published on 2022-10-012022-10-05 Journal: European Journal of Integrative Medicine [Category] [DOI] 10.1016/j.eujim.2022.102179 [Article Type] Research article
Adding colchicine to tocilizumab in hospitalized patients with severe COVID-19 pneumonia: An open-label randomized controlled trialArticle Published on 2022-09-302022-11-15 Journal: Medicine [Category] [DOI] 10.1097/MD.0000000000030843 PMC 바로가기
A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)Article Published on 2022-09-272022-11-15 Journal: BMC Medicine [Category] [DOI] 10.1186/s12916-022-02518-7 PMC 바로가기
Effectiveness and safety of fibrinolytic therapy in critically ill patients with COVID-19 with ARDS: protocol for a prospective meta-analysisArticle Published on 2022-09-262022-11-16 Journal: BMJ Open [Category] [DOI] 10.1136/bmjopen-2022-063855 PMC 바로가기
Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trialArticle Published on 2022-09-202022-11-16 Journal: Trials [Category] [DOI] 10.1186/s13063-022-06723-w PMC 바로가기
Reactogenicity and immunogenicity of the second COVID-19 vaccination in patients with inborn errors of immunity or mannan-binding lectin deficiencyArticle Published on 2022-09-142022-11-15 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.974987 PMC 바로가기
Efficacy and safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive and biological therapy: Prospective observational studyObservational Study Published on 2022-09-022022-10-05 Journal: PLoS ONE [Category] [DOI] 10.1371/journal.pone.0273612 PMC 바로가기 [Article Type] Observational Study